Literature DB >> 32352618

Emergency room neurology in times of COVID-19: malignant ischaemic stroke and SARS-CoV-2 infection.

T González-Pinto1, A Luna-Rodríguez1, A Moreno-Estébanez1, G Agirre-Beitia1, A Rodríguez-Antigüedad1, M Ruiz-Lopez1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; malignant stroke; neurology

Year:  2020        PMID: 32352618      PMCID: PMC7267343          DOI: 10.1111/ene.14286

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.288


× No keyword cloud information.

Introduction

The COVID pandemic has severely ravaged through Spain over the past weeks. The increasing number of affected patients in a short time required a quick reorganization of our healthcare system in order to encompass this huge amount of work and avoid the collapse of hospitals. It is a formidable effort for everyone and many of our colleagues have acquired infection in this process. The case of a 36‐year‐old woman who was a healthcare worker and was brought by ambulance to the emergency room is reported.

Case report

Her mother had to contact the police because she was unable to talk to her on the phone for the last 48 h. She was found lying on her apartment floor unable to talk nor to move the right side of her body. She was on her own because her partner was taking care of his parents when the lockdown started and decided to stay with them during the state of emergency. She was a smoker, but no other previous medical history was known. Physical examination revealed a global aphasia and a right hemiplegia (National Institutes of Heart Stroke Scale 21). Computed tomography (CT) of the brain showed an established infarct in the territory of the left middle cerebral artery with a mild deviation of the midline (Fig. 1a). CT angiography showed an occlusion of the left internal carotid artery, middle cerebral artery and the left anterior cerebral artery with a free‐floating thrombus in the ascending aorta with no signs of aortic atheromatosis (Fig. 1b, c). A thoracic CT revealed bilateral pneumonia and signs of bilateral acute pulmonary embolism. Polymerase chain reaction test for SARS‐CoV‐2 was performed and was positive. Blood tests revealed elevated creatine kinase (8669 U/l) and D‐dimer levels (7540 ng/ml), a C‐reactive protein of 156 mg/L and 23 600 white blood cells/µl. [Correction added on 17 July 2020 after first online publication: '156 mg/ml' has been amended to '156 mg/L' in the preceding sentence.] Because of the delay, the severe mass effect and the poor clinical status, it was decided not to perform hemicraniectomy. Her level of consciousness gradually deteriorated, and she passed away 72 h after admission.
Figure 1

(a) CT scan of the brain showed an established subacute infarct in the territory of the left middle cerebral artery with a mild deviation of the midline. (b) CT angiography shows the occlusion of the left internal carotid artery. (c) CT angiography shows a free‐floating thrombus in the ascending aorta.

(a) CT scan of the brain showed an established subacute infarct in the territory of the left middle cerebral artery with a mild deviation of the midline. (b) CT angiography shows the occlusion of the left internal carotid artery. (c) CT angiography shows a free‐floating thrombus in the ascending aorta.

Discussion

The major clinical manifestations of the SARS‐CoV‐2 infection are mainly due to pulmonary complications [1]. To date, the incidence of neurological symptoms in COVID patients remains unknown and, although several neurological symptoms have been reported, the biological mechanism remains unknown [2]. It is well known that COVID infection can induce changes in coagulation and other laboratory findings such as thrombocytopenia, elevated D‐dimers, prolonged prothrombin time, and disseminated intravascular coagulation which can lead to the development of thrombosis. However, its effects on systemic circulation and coagulation have not yet been established [3, 4]. Under these circumstances, neurologists were fearing the collapse of our units and planning how to deal with the potential increase of our stroke patients. Surprisingly, a substantial reduction of neurological emergencies has been experienced during on‐calls. This raises the question of whether these patients are being overlooked. It is believed that this case illustrates the strong association between SARS‐CoV‐2 and the development of systemic thromboembolisms due to a hypercoagulable state, no matter the age of the patient. Thus, the awareness of neurologists about severe forms of systemic ischaemia and stroke in patients with signs of COVID infection need to be increased in order to provide all patients with the best possible care.

Disclosure of conflicts of interest

The authors declare that they have no conflicts of interest.
  4 in total

1.  Neurologic complications of coronavirus infections.

Authors:  Avindra Nath
Journal:  Neurology       Date:  2020-03-30       Impact factor: 9.910

2.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Ling Mao; Huijuan Jin; Mengdie Wang; Yu Hu; Shengcai Chen; Quanwei He; Jiang Chang; Candong Hong; Yifan Zhou; David Wang; Xiaoping Miao; Yanan Li; Bo Hu
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

Review 3.  Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.

Authors:  Dimitrios Giannis; Ioannis A Ziogas; Panagiota Gianni
Journal:  J Clin Virol       Date:  2020-04-09       Impact factor: 3.168

4.  Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.

Authors:  Yan Zhang; Meng Xiao; Shulan Zhang; Peng Xia; Wei Cao; Wei Jiang; Huan Chen; Xin Ding; Hua Zhao; Hongmin Zhang; Chunyao Wang; Jing Zhao; Xuefeng Sun; Ran Tian; Wei Wu; Dong Wu; Jie Ma; Yu Chen; Dong Zhang; Jing Xie; Xiaowei Yan; Xiang Zhou; Zhengyin Liu; Jinglan Wang; Bin Du; Yan Qin; Peng Gao; Xuzhen Qin; Yingchun Xu; Wen Zhang; Taisheng Li; Fengchun Zhang; Yongqiang Zhao; Yongzhe Li; Shuyang Zhang
Journal:  N Engl J Med       Date:  2020-04-08       Impact factor: 91.245

  4 in total
  39 in total

1.  Shortcomings of Rapid Clinical Information Dissemination: Lessons From a Pandemic.

Authors:  K H Vincent Lau; Pria Anand
Journal:  Neurol Clin Pract       Date:  2021-06

Review 2.  Nervous System Involvement in COVID-19: a Review of the Current Knowledge.

Authors:  Mahnaz Norouzi; Paniz Miar; Shaghayegh Norouzi; Parvaneh Nikpour
Journal:  Mol Neurobiol       Date:  2021-03-25       Impact factor: 5.590

3.  Focal neurological deficits from multiple thromboembolic stroke complicating COVID-19 and limitations of stroke management during outbreak in Korea.

Authors:  Soo-Hyun Park; Woo Chang Chun
Journal:  Neurol Sci       Date:  2021-08-25       Impact factor: 3.307

4.  Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series.

Authors:  Sujan T Reddy; Tanu Garg; Chintan Shah; Fábio A Nascimento; Rajeel Imran; Peter Kan; Ritvij Bowry; Nicole Gonzales; Andrew Barreto; Abhay Kumar; John Volpi; Vivek Misra; David Chiu; Rajan Gadhia; Sean I Savitz
Journal:  Case Rep Neurol       Date:  2020-06-11

5.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Authors:  Aravinthan Varatharaj; Naomi Thomas; Mark A Ellul; Nicholas W S Davies; Thomas A Pollak; Elizabeth L Tenorio; Mustafa Sultan; Ava Easton; Gerome Breen; Michael Zandi; Jonathan P Coles; Hadi Manji; Rustam Al-Shahi Salman; David K Menon; Timothy R Nicholson; Laura A Benjamin; Alan Carson; Craig Smith; Martin R Turner; Tom Solomon; Rachel Kneen; Sarah L Pett; Ian Galea; Rhys H Thomas; Benedict D Michael
Journal:  Lancet Psychiatry       Date:  2020-06-25       Impact factor: 27.083

Review 6.  Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.

Authors:  Michael T Heneka; Douglas Golenbock; Eicke Latz; Dave Morgan; Robert Brown
Journal:  Alzheimers Res Ther       Date:  2020-06-04       Impact factor: 6.982

7.  COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature.

Authors:  Ying-Kiat Tan; Claire Goh; Aloysius S T Leow; Paul A Tambyah; Alicia Ang; Eng-Soo Yap; Tian-Ming Tu; Vijay K Sharma; Leonard L L Yeo; Bernard P L Chan; Benjamin Y Q Tan
Journal:  J Thromb Thrombolysis       Date:  2020-10       Impact factor: 5.221

Review 8.  Neurological associations of COVID-19.

Authors:  Mark A Ellul; Laura Benjamin; Bhagteshwar Singh; Suzannah Lant; Benedict Daniel Michael; Ava Easton; Rachel Kneen; Sylviane Defres; Jim Sejvar; Tom Solomon
Journal:  Lancet Neurol       Date:  2020-07-02       Impact factor: 44.182

Review 9.  Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.

Authors:  Ghazal Aghagoli; Benjamin Gallo Marin; Nicole J Katchur; Franz Chaves-Sell; Wael F Asaad; Sarah A Murphy
Journal:  Neurocrit Care       Date:  2021-06       Impact factor: 3.532

Review 10.  Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.

Authors:  Shigeru Shibata; Hisatomi Arima; Kei Asayama; Satoshi Hoshide; Atsuhiro Ichihara; Toshihiko Ishimitsu; Kazuomi Kario; Takuya Kishi; Masaki Mogi; Akira Nishiyama; Mitsuru Ohishi; Takayoshi Ohkubo; Kouichi Tamura; Masami Tanaka; Eiichiro Yamamoto; Koichi Yamamoto; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2020-07-31       Impact factor: 5.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.